FDA: Eyelash Thickener Claims Misleading
Web Site for Latisse Avoids or Downplays Side Effects Associated with Product (Source: Health News: CBSNews.com)
See more here:
FDA: Eyelash Thickener Claims Misleading
bimatoprost, Latisse, Lumigan
Title: bimatoprost, Latisse, LumiganCategory: MedicationsCreated: 5/1/2009Last Editorial Review: 5/1/2009 (Source: MedicineNet Medications General)
Original post:
bimatoprost, Latisse, Lumigan
FDA Approves Allergan’s Drug for Longer Eyelashes
Allergan Inc, maker of Botox, said on Friday that the U.S. Food and Drug Administration has approved its eyelash-thickening drug Latisse. Reuters Health Information (Source: Medscape Medical News Headlines)
Read the original post:
FDA Approves Allergan’s Drug for Longer Eyelashes
FDA OKs 1st Eyelash Drug Latisse
Title: FDA OKs 1st Eyelash Drug LatisseCategory: Health NewsCreated: 12/29/2008Last Editorial Review: 12/29/2008 (Source: MedicineNet Eyesight General) MedWorm Message: Register for MedMatcha, MedWorm’s medical advertising network , and receive $5 free advertising.
Originally posted here:
FDA OKs 1st Eyelash Drug Latisse
FDA OKs Latisse For Hypotrichosis of Eyelashes Treatment
New prescription drug Latisse increases the length, thickness and darkness of eyelashes.
See the original post here:
FDA OKs Latisse For Hypotrichosis of Eyelashes Treatment
Allergan Gets Nod For Eyelash Treatment
Eye care and cosmetic drug maker Allergan on Friday said its eyelash growth treatment Latisse received Food and Drug Administration approval,… (Source: Investor’s Business Daily: HEALTH)
Read more:
Allergan Gets Nod For Eyelash Treatment
FDA Advisory Committee Unanimously Recommends Approval of Latisse (Bimatoprost Solution 0.03%) as a Treatment for Hypotrichosis of Eyelashes
IRVINE, Calif.–(BUSINESS WIRE)–Dec 5, 2008 – Allergan, Inc. today announced the U.S.
